We have previously noted that when Friend erythroleukemia cells (FLC)' (H-2a) passaged intraperitoneally in DBA/2 mice were injected subcutaneously or intraperitoneally into adult allogeneic immunocompetent mice, they multiplied rapidly in the first few days before their further growth was abruptly arrested . In contrast, FLC injected intravenously into allogeneic adult C57B1/6 mice, implanted in the liver and spleen, but did not multiply to any significant degree ; whereas in syngeneic DBA/2 mice, they multiplied rapidly and preferentially in these organs and killed all the mice between 7 and 12 d (1). These observations suggested that when FLC were injected subcutaneously or intraperitoneally the growing tumors were rejected after several days in allogeneic mice, whereas when the same cells were injected intravenously and lodged in the liver and spleen they simply could not multiply in these organs in adult allogeneic mice . It seems plausible that the mechanisms underlying the host response to these tumor cells in these different tissues are different.
Our previous work has suggested that IFN-a/R may constitute an important host defense against the growth of transplantable tumors : (a) treatment of athymic nude mice with anti-mouse IFN-a/p globulin markedly enhanced the subcutaneous growth and metastatic capacity ofseveral xenogeneic cell lines (2); (b) in adult immunocompetent mice, administration of anti-mouse IFN-a/0 globulin enhanced the growth of a variety of transplantable murine tumors injected subcutaneously or intraperitoneally in syngeneic mice but did not abrogate the capacity of allogeneic mice to reject the growing tumors (3) .
In the studies reported herein, we show that administration of antibodies to IFNa/R completely abrogates the resistance of adult C57B1/6 (H-2') and C3H (H-2') mice to the rapid multiplication of FLC in the liver. Our results suggest that the endogenous IFN-a/R induced by intravenous injection of FLC is a crucial component in the resistance of the liver to the multiplication of these allogeneic tumor cells .
Materials and Methods

Mice
Adult DBA/2, C57BI/6, C3H, BALB/c mice were obtained from the pathogen-free breeding colonies of the Institut de Recherches Scientifiques sur le Cancer (Villejuif) . Fl hybrid mice were obtained by mating male or female C57B1/6 with male or female BALB/c . In two experiments, BALB/cBy, C57Bl/6By, and congenic B6 .C-H-2d (HW19) mice (4) were a generous gift of Dr. Edward De Maeyer (Institut Curie, Orsay, France). In all experiments (unless otherwise specified) adult mice >6 wk old were used .
Mx' -congenic Mice
The congenic B .6A2G-Mx (N20,F4) mouse strain (5) was produced at the Institute for Immunology and Virology of the University of Zurich by introducing . the influenza virus resistance allele Mx' of A2G mice (6) into virus-susceptible C57BI/6 mice.
Tumor Cells
The IFN-a/0 resistant clone, 3C18, of FLC passaged in vitro was obtained from Dr. Affabris, Istituto Superiore di Sanit3, Rome, Italy (7) . These cells were subsequently passaged in our laboratory by weekly intraperitoneal injection of DBA/2 mice (H-2d) and were highly metastatic for the liver and spleen (1, 8, 9) . In the experiments to be described, tumor cells were harvested while in the exponential growth phase in the peritoneum .
Quantitative Estimation of the Number of FLC in Liver and Spleen
Colony Formation in Agarose. The liver or spleen was cut into small pieces with a scalpel and suspended in 20 ml of a prewarmed (37°C) solution of collagenase 100 U/ml (crystalline collagenase 156 U/mg CLSII ; Worthington Biochemical Corp., Freehold, NJ), in RPMI 1640 nutrient medium (Flow Laboratories, Irvine, Scotland) without serum (1) . After gentle mixing on a magnetic stirrer at 37°C for 45 min, the cell suspension was centrifuged, and the cell pellet was resuspended in 4 ml (liver) or 2 ml (spleen) of RPMI 1640 medium supplemented with 10% FCS (Flow Laboratories) . The total number of FLC recovered was calculated by the number of FLC colonies in agarose according to techniques previously described (10) . Cells from the liver of normal adult mice do not form colonies in agarose, and only very few colonies were obtained from the spleen of normal mice (<10 3 /spleen) (1) . These colonies could easily be distinguished morphologically from typical FLC colonies in agarose .
Irradiation of FLC
FLC in a petri dish were irradiated with 50 Gy (5,000 rad) : (cesium Y rays : 200 rad/min) by Dr. M . Guichard, H8pital Gustave Roussy, Villejuif, France .
Hyperimmune Anti-IFN Globulins and Normal Serum Globulins
The sources and activities of the different Ig preparations are shown in Table I . All sera were decomplemented and extensively absorbed on murine cells (11) . The Ig fractions were separated by ammonium sulfate precipitation (protein content varied between 20 and 33 mg/ml) and were shown to be devoid of any cytotoxicity (11) . The anti-mouse IFNa/0 globulins did not neutralize IFN-y .
Sheep Nos . 1 and 5A were immunized with partially purified IFN-a/Q (11), whereas sheep No . 18-2 was immunized only with highly purified mouse IFN-a/0 (12) . Sheep (Mona) polyclonal antibody to IFN-a/P(K) (prepared in mouse L cells) serves as the National Institutes of Health (Bethesda, MD) reference antibody (13) . Anti-mouse IFN-0 mAb was produced and partially purified in our laboratory (F Belardelli) from the hybridoma cell line 7F-D3 (14) ; a generous gift of Dr. Y. Kawade, Institute for Virus Research, Kyoto, Japan . The R4-6A2 rat:mouse hybridoma cell line was kindly provided by Dr. E. Haven (Trudeau Institute, Saranac Lake, NY) (15) . The crude tumor ascites was partially purified by Dr. R. Marcowitz in our laboratory by precipitation with 45% ammonium sulfate. The anti-mouse IFN-y showed no neutralizing activity at a 1 :40 dilution against 8 U of mouse IFN-a/0.
The polyclonal sheep anti-mouse IFN-a/0 globulins were shown to be completely devoid of any anti-H-2 d, anti-H-2 n, or H-2k activity at a 1 :2 dilution (these tests were kindly performed by Dr. M . Pla, Laboratory of Mouse Immunogenetics, H6pital Saint-Louis, Paris, France).
IFN Neutralization Assay
Serial twofold dilutions of Ig were incubated for 1 h at 37'C and 2 h at VC with 4-8 U of mouse IFN-a/0 (C-243 cell IFN) or mouse IFN-y. Mixtures were then incubated with monolayer cultures of L cells for 18 h before challenge with -100 tissue culture infective doses (TCID50) of vesicular stomatitis virus (VSV). In each instance a simultaneous titration of the IFN used was included in the test . The neutralizing titer was taken as the highest dilution of antibody that inhibited by 50% the protective activity of 4-8 U of IFN. A PHA-induced spleen cell IFN preparation partially purified on Con A-Sepharose columns was provided by Dr. E. A. Haven (Trudeau Institute, Saranac Lake, NY).
Anti-Mx Antibody and Immunofluorescence Assay for the Mx Protein
AP5 is a monospecific anti-Mx antibody produced by immunizing rabbits with a synthetic peptide corresponding to the COOH terminus of murine Mx protein (position 616-631) (16 (17) (18) (19) and was provided by Dr. P. Staeheli (Research Institute of Scripps Clinic, La Jolla, CA) .
Frozen 6-8-um cryostat sections of liver and spleen were fixed and permeabilized in 3 % paraformaldehyde and 0.5% Triton X-100 as described (18) and were then incubated for 15 min with appropriate dilutions of rabbit antibody AP5 . Bound antibody was revealed with rhodamin (TRITC)-conjugated goat anti-rabbit IgG (Cappel Laboratories, Cochranville, PA) . A Reichert Jung Polyvar microscope was used for UV incident light fluorescence microscopy.
Detection of mRNA for Murine Interferons in Organs of Mice
Extraction of RNA from Liver and Spleen. Quick frozen liver or spleen was homogenized in lysis buffer (6 M urea/3 M LiCI/0 .1% NaDodS04/heparin 20 U/ml/10 mM sodium acetate, pH 5.0) and the RNA was precipitated at 0°C, extracted twice with phenol/chloroform, and chromatographed twice on oligo(dT)-cellulose . Poly(A)' RNA was recovered by precipitating the RNA with 2.5 vol of ethanol at -20'C overnight and ultracentrifuging the RNA precipitate (100,000 g for 1 h).
RNA Blot Hybridization . RNA was electrophoresed in 1.5 % agarose gels in the presence of formaldehyde, transferred to nylon filters (Hybond-N; Amersham Corp., Arlington Heights, IL) in the presence of 20x SSC (1 x SSC : 0.15 M NaCI/7 .5 mM sodium citrate), and irradiated for 4 min at 312 nm (180 W). The RNA blots were prehybridized in 5 x SSC/1 x Denhardt's reagent (0.02 0/c polyvinylpyrrolidone/0.02 % Ficoll/0.02 % BSA/100 mM sodium phosphate buffer, pH 6.5/0.1% NaDodS04/denatured salmon sperm DNA (100 wg/ml) at 68'C for 4 h.
RNA was then hybridized to a 600-bp Bam HI-Hinc II fragment of the mouse IFN-a2 gene (20) cloned into the vector pSP64 (21), a cDNA clone of the mouse IFN-0 gene (22) , and a 330-bp Hind III-Cla I fragment containing the first exon of the mouse IFN--t gene (23) cloned into the vector pBR322 labeled by nick translation to a specific radioactivity of 0.5-4 x 109 cpm/wg of DNA using a-[ 32P]dATP and a-[ 32P]dCTP (6,000 Ci/mmol; Amersham Corp.). The blots were hybridized at 68'C for 20 h in a fresh aliquot of the above solution. The filters were then washed at 42'C for 2 h in a buffer containing 50% deionized formamide/5 x SSC/100 mM sodium phosphate and then were repeatedly washed in 0.1 x SSPE/0.1% NaDodS04 at room temperature . The filters were then exposed to Fuji RX film with a Cronex intensifying screen (DuPont Co., Wilmington, DE) at -800C .
Results
Role of the MHC in Determining the Multiplication of FLC in the Liver after Intravenous Inoculation FLC Injected Intravenously in BALEIc (H-2d) and C57BI16 Mice (H-2b), in FI Hybrid Mice, and in C57BI16 Mice Congenic with BALBIc Mice at the MHC Locus . FLC passaged in syngeneic DBA/2 mice (H-2d) are highly tumorigenic (10) and when injected intravenously they rapidly multiply in the liver and spleen (1) ; previous work has shown that intravenous inoculation of approximately four FLC constitutes 1 LD5o for adult DBA/2 mice (1) . FLC also multiplied extensively in the livers of BALB/c (H-2d) mice but not at all in the livers of adult C57B1/6 (H-2b) mice. We wanted to determine whether FLC would also multiply in the livers of C57B1/6 mice congenic with BALB/c mice at the MHC locus . It is clear from the results presented in Fig . 1 A that fewer FLC were recovered from the livers of congenic mice than from the livers of BALB/c mice. Likewise, 6 d after intravenous inoculation fewer FLC were recovered from the livers of Fl C57B1/6 x BALB/c hybrid mice ( Fig. 1  B) than from the livers of BALB/c mice. These results indicated that permissivity for the multiplication of FLC in the liver after intravenous inoculation was not determined solely by the MHC, and that other factors might be involved . AMOUNT OF ANTIBODY INJECTED. FLC multiplied in the livers of C57B1/6 mice pretreated with 2 x 106 , 2 x 10 5 , and 2 x 104 neutralizing units of antibody to IFNa//3 but not in mice injected with 2 x 103 , 2 x 10 2 neutralizing units (Fig . 4) .
NUMBER OF FLC INJECTED. Although in the experiments described above mice were injected intravenously with 2 x 10 6 FLC, it can be seen from phenomenon of abrogation by anti-IFN globulin of the resistance of C57B1/6 to the multiplication of FLC in the liver was observed for all groups regardless of the number of FLC injected at the dose of antibody injected .
AGE OF MICE . Although FLC injected intravenously do not multiply in the livers of 6 wk and older C57B1/6 mice, FLC do multiply in the livers of some 4-wk-old mice (Fig . 6 ) . FLC did multiply in the livers of all 4-and 12-wk-old mice treated with anti-IFN-a/p globulin (Fig . 6) . TIME OF INJECTION OF ANTI-IFN GLOBULIN . Injection of anti-IFN-a/0 globulin 3 h before intravenous injection of FLC was more effective in abrogating the resistance of C57B1/6 mice to multiplication of FLC in the liver than injection of the same amount of globulin 2 or 3 d before tumor cell inoculation (however, this treatment was also effective) (data not shown) . The somewhat lower efficacy of anti-IFNa/(3 globulin injected 2-3 d before FLC injection was probably due to the progressive decrease in the circulating serum titer of the anti-IFN globulin in the days after injection- (11) .
RELATIVE NUMBER OF FLC IN LIVER AND SPLEEN . After intravenous inoculation of syngeneic DBA/2 mice, FLC multiply extensively and equally in both the liver and spleen (1) . In C57B1/6 mice treated with anti-IFN-a/D globulin, 1,000-fold more FLC were recovered from the liver than from the spleen (Fig. 7) . There was, nevertheless, a difference between the number of FLC recovered from the spleen of antibody treated mice compared with control-treated C57B1/6 mice ( abrogation of resistance did not stem from a peculiarity of this particular sheep Ig may be summarized as follows. Polyclonal anti-IFN-a/p globulin from another source (Dr. Y Kawade, Institute for Virus Research, Kyoto, Japan) also abrogated the resistance of C57B1/6 mice to the multiplication of FLC in the liver (Fig . 8 A) . Likewise, polyclonal anti-IFNa/P globulin from two other sheep immunized in our laboratory (one with partially purified interferon [5A] [11] and the other with highly purified interferon ) was also equally effective in abrogating resistance in C57B1/6 mice (data not shown) . In contrast, normal sheep serum globulins (the preimmunization serum globulins of sheep No. 18 ; and sheep No. 2, and the serum globulin from sheep No. 11 immunized with the impurities in the IFN preparations) did not abrogate the resistance of C57B1/6 mice, and FLC did not multiply in the livers of these mice (data not shown) . 10 Administration of monoclonal anti-mouse IFN-R Ig was ineffective in C57B1/6 mice ( Fig . 8 A) , and monoclonal anti-IFN-y Ig was ineffective in C57111/6 and C3H mice (Fig . 8, B and C) .
Antibody to IFN-a/# also Abrogates the Resistance of C3H Mice (H-2k) to the Multiplication of FLC in the Liver. The experiment illustrated in Fig. 8 (C) shows that polyclonal antibody to IFN a/a also abrogates the resistance of C3H mice (H-2') to the multiplication of FLC in the liver.
Reproducibility of the Efect of Polyclonal Antibody to IFN-a/J3 on the Multiplication of FLC in the Liver of Adult C57B1/6 Mice. As can be seen in Table II , treatment of adult C57B1/6 mice with polyclonal antibody to IFN-a/D consistently abrogated the resistance of the liver to multiplication of FLC, whereas FLC did not multiply in the livers of adult C57B1/6 mice treated with control globulins or left untreated.
Injection of Anti-Mouse IFN-a/(3 Globulin Results in Death of C57B1/6 and C3H Mice Injected Intravenously with 3C18 FLC. In six experiments some C57B1/6 or C3H mice treated with anti-IFN-a/p globulins or control globulins were kept for at least 2 mo to determine the effect of antibody treatment on long-term survival . As can be seen from Table III, 
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Demonstration of mRNA in the Livers of C57BI16 Mice Injected with 308 FLC Which Hybridizes with Mouse IFN-a and -ll DNA Probes . In three experiments using cell culture IFN assays, we could demonstrate an antiviral inhibitor (at serum dilutions of 1 :10 to 1 :40) in most pools of sera from C57B1/6 mice 24 h (but not at 48 h) after inoculation of 2 x 106 3C18 FLC. As the activity of this inhibitor was low it was difficult to characterize it, so we determined whether injection of FLC induced the appearance of mRNA hybridizable with specific mouse IFN-a or -Q cDNA probes .
In four experiments, poly(A)' RNA harvested from the liver of C57B1/6 mice 8 h after inoculation of FLC hybridized with the mouse IFN-a2 probe. No hybridization was detected with RNA from the livers of mice taken 24 h after injection of FLC or with RNA prepared from uninjected mice (Fig. 9 A) . A lower signal of hybridization was observed with the IFN-a2 probe for poly(A)' RNA extracted from the spleen 24 h after injection of FLC (data not shown) . Newcastle Disease virus (NDV)-induced IFN-a mRNA in the spleen had an approximate size of 1.2 kb (Fig . 9 A) . In each experiment the size of the hybridizable RNA in the liver (8 h) or spleen (24 h) after inoculation of FLC was -1.5 kb .
In two experiments, poly(A)' RNA harvested from the liver of mice 8 h after inoculation of FLC (but not after 24 h nor from uninoculated mice) hybridized with the mouse IFN-a probe (Fig . 9 B) . NDVinduced IFN-R mRNA in the spleen had an approximate size of 0.9 kb, whereas the RNA in the liver of FLC-injected mice had an approximate size of 1.2 kb. Effects of anti-IFNa/P globulin on the recovery of FLC from the liver and spleen of C57BI/6 mice . 9-wk-old male C57131/6 mice were injected with 2 x 106 neutralizing units of sheep (Table II) Hybridizable RNA was not detected in extracts ofkidney, lung, thymus, or mesenteric ganglion using the mouse IFN-a2 or -R probes . No hybridizable RNA was detected in organ extracts using a mouse IFN-y probe (data not shown) .
Induction ofMx Protein Expression in C57B1/6 Mice Congenic with A2G Mice at the Mx Locus. The preceding experiments showed that after intravenous injection ofFLC, mRNA hybridizing with cDNA probes for mouse IFN-a and -a was present in the In all these experiments adult C57B1/6 mice (>6 wk old) were injected intravenously with >2 x 106 3C 18 FLC . To determine FLC multiplication, the number of FLC in the liver was determined between the fifth and ninth day after intravenous inoculation .
liver at 8 h, and a viral inhibitor was present in very low titer of the serum at 24 h. As mouse IFN-a/Q (but not IFN-y) induces the expression of the Mx protein in Mx`mice (24, 25) we determined whether inoculation of FLC into C57B1/6 mice congenic with A2G mice at the Mx locus would result in the expression of the Mx protein in the liver and spleen, thus constituting further evidence that injection of FLC results in the production of IFN-a/(3 .
Accordingly, congenic B6 .A2G-Mx mice were injected intravenously with 2 x 10 6 3C18 FLC and organs were harvested 3, 5, and 7 d thereafter. In uninoculated Mx' mice there is a background level of Mx protein expressed in a subset of cells in the liver and spleen (probably in macrophages and endothelial cells) (18, 24) (Fig.  10, A and D) , but it is less prominent in other organs . In Mx' mice injected intravenously with FLC, there was an induction of Mx expression in most hepatocytes (Fig . 10 E) , and cells of the white pulp of the spleen (Fig. 10 B) , kidney, and lung (data not shown) . Administration of anti-IFN-a/0 globulin markedly inhibited this induced expression of the Mx protein in both the liver and spleen of FLC-injected mice (Fig . 10, C and F) , although it did not appear to affect the low background level of spontaneous Mx expression (Fig . 10 , compare A and D with C and F) . The preceding results indicated that after intravenous inoculation, FLC multiplied in the livers of C57B1/6 or C3H mice treated with antibody to mouse IFNa/(3 . It might be hypothesized that injection of FLC from syngeneic DBA/2 mice into these anti-IFN globulin-treated allogeneic mice resulted in the selection of a population of tumor cells (perhaps with an altered H-2 expression) capable of multiplying in untreated C57B1/6 mice. Likewise, it might be hypothesized that injection of FLC liberated a factor (virus ?) that induced a transformation of host cells in C57B1/6 mice treated with anti-IFN-a/R globulin . We undertook two experiments to test these hypotheses .
First, FLC were serially passaged every 7 d for 10 passages in C57B1/6 mice treated with 10 6 neutralizing units of anti-mouse IFN-a/0 globulin . At each passage, 2 x 106 FLC from the livers of antibody treated mice were injected intravenously into three other antibody-treated or three untreated mice. At each passage level, FLC multiplied only in the livers of mice pretreated with antibody to IFN-a/0 and never in the livers of untreated mice . After the second and tenth passage of FLC in the livers of antibody-treated mice, these FLC were injected both intravenously and subcutaneously into untreated allogeneic C57B1/6 mice and also into syngeneic DBA/2 mice. FLC formed large subcutaneous tumors and multiplied extensively in the livers of DBA/2 mice (compared in the same experiment with FLC passaged intraperitoneally in DBA/2 mice) but did not multiply in untreated C57B1/6 mice . These results indicated that passage of FLC in the livers of antibody-treated C57B1/6 mice was not associated with acquisition of the capacity to multiply in the livers (or subcutane-FIGURE 10 . Induction of Mx protein expression in Mx' C57B1/6 mice injected intravenously with 308 FLC. 5-mo-old male congenic B6 .A2G-Mx' mice were separated into three groups. One group was not injected (A, D) ; one group was injected (0 .2 ml i.p .) with normal sheep 2 serum globulin (B, E) ; one group was injected with 2 x 10 6 i.p. neutralizing units of sheep 1 anti-IFN-a/p globulin C, F). 3 h later mice in groups B, C, E, and F were injected intravenously with 2 x 10 6 3C18 FLC. ously) of untreated allogeneic C57B1/6 mice or in a decreased tumorigenicity for syngeneic DBA/2 mice.
In a second experiment, FLC were irradiated with 5,000 rad, which abolished their capacity to multiply in the liver of C57B1/6 mice treated with anti-IFN-a/P globulin (or left untreated) . These results indicated that the injected FLC must have the capacity to multiply in order to induce tumors in the livers of C57B1/6 mice treated with antibody to IFN-a/(3 . These results do not support, therefore, the hypothesis that virus released from FLC induced a transformation of host cells.
Discussion
The results presented herein suggest the possibility that the mechanisms operative in restricting transplantable tumor growth in allogeneic mice may be different depending on the site of tumor growth . For example, transplantable mouse tumors usually grow for several days when injected subcutaneously or intraperitoneally into allogeneic mice before rejection. Thus, in previous experiments FLC (H-2 d) injected intraperitoneally into allogeneic C57B1/6, C3H, or Swiss mice multiplied 500-fold in the peritoneum by the fifth day (comparable numbers of FLC were present in the peritoneum of syngeneic mice at this time) before being eliminated in the ensuing few days (our unpublished observations). It is usually accepted that immune mechanisms are responsible for this tumor cell rejection across a strong MHC barrier (26) .
In contrast, when FLC were injected intravenously they implanted in the liver of syngeneic DBA/2 and allogeneic C57B1/6 mice to the same extent (see Fig. 2 ; 3 h after injection), but multiplied only in the livers of syngeneic mice and not to any significant degree in the livers of adult allogeneic mice . We are not aware of a distinction having been made, heretofore, between rejection of a growing tumor and failure of the tumor to grow at all in the adult allogeneic host . Furthermore, the behavior of tumor cells injected intravenously into hybrid or congenic mice suggested that factors in addition to the MHC may be important in restricting tumor growth in different organs after intravenous inoculation. Thus, several days after intravenous inoculation, 100-fold fewer FLC could be recovered from the livers of C57B1/6 mice congenic with BALB/c mice at the MHC locus (or from F1 hybrid C57B1/6 x BALB/c mice) than from the livers of BALB/c mice (H-2 d) (Fig . 1) . Likewise, after intravenous inoculation of the B16 melanoma, -10-fold fewer tumor nodules were observed in the lungs of F1 hybrid mice compared with the lungs of syngeneic mice (27) . In contrast, no difference was observed in mesenteric tumor formation between syngeneic and F1 hybrid mice when the tumor cells were injected intraperitoneally (27) . Jack and McVeigh concluded that after intravenous injection, tumor growth in the lung was restricted by a "locus other than H-2" (27) .
The results presented herein strongly suggest that IFN-a/0 is one of the important factors in restricting FLC multiplication in the liver after intravenous inoculation of allogeneic mice . Whereas administration of antibody to IFN-a/a did not prevent tumor cell rejection when tumor cells were injected subcutaneously or intraperitoneally into allogeneic mice (3), this antibody completely overcame the barrier to FLC multiplication in the livers of adult allogeneic immunocompetent mice . Thus, in antibody-treated C57B1/6 or C3H mice, FLC injected intravenously multiplied rapidly in the liver (as determined by quantitative estimations of the number of FLC [Figs. 2, [4] [5] [6] [7] [8] and histopathologic examination [ Fig . 3] ) and almost all the mice died with extensive tumor invasion of the liver (Table III) . In fact, the kinetics of FLC muliplication in the liver of C57B1/6 mice treated with anti-IFN-a/R globulin (Fig . 2) and the mean day of death of these mice resembled that observed in syngeneic DBA/2 mice. The effect of antibody treatment of allogeneic mice in abrogating liver resistance was highly reproducible (Table II) under a variety of experimental conditions (i .e., varying numbers of FLC injected, age of mice, amount of antibody) as detailed in Figs . 4-6. Several arguments attest to the specificity of the antibodies to IFN-a/R used : (a) Polyclonal antibodies raised in three sheep in our laboratory against either partially purified C243 cell IFN-a/(3 (sheep 1-8, and 5A), or highly purified mouse IFN-a/0 (12) (sheep 18), or antibody from a sheep (Mona) prepared in another laboratory against mouse L cell IFN all proved effective in abrogating the resistance of C57B1/6 or C3H mice to the multiplication of FLC in the liver (Table I, Fig. 8 ) . (b) Neither antibody raised in sheep 11 against the impurities in the IFN-a/(3 preparations or the serum globulin from two normal sheep (one being the preimmunization serum of sheep 18) exerted any effect .
These considerations suggest that these anti-IFN-a/R globulins acted by neutralizing either "spontaneous" endogenous IFN-a/R present before injection of tumor cells or an endogenous IFN-a/0 resulting from the intravenous injection of FLC. Although we have not detected IFN in normal mice, other investigators have demonstrated the presence of small amounts of IFN-a/0 in the serum of a few normal mice (28) and our previous work using antibody to IFN-a/0 has provided indirect evidence to suggest the presence of biologically active "spontaneous" endogenous IFN in mice (29) (30) (31) . More recently we have shown that the mRNA for IFN-al and -a2 is present in various tissues of normal individuals in the apparent absence of an inducer (32) .
To our knowledge there have been very few previous reports demonstrating the production of interferon in experimental animals after inoculation of tumor cells (33, 34) , although tumor cells have been shown to induce interferon production by lymphocytes in vitro (35, 36) . Several experimental results strongly indicated that in our experiments the intravenous inoculation of FLC does result in the induction of IFN : (a) 8 h after intravenous inoculation of FLC, poly(A) + RNA hybridizable with specific DNA probes for mouse IFN-a2 and -R was detectable in the liver (Fig.  9 ) (hybridizable poly(A)' RNA was also present in the spleen at 24 h) .2 (b) Using IFN cell culture assays a viral inhibitor of low activity was detected in the serum of C57B1/6 mice 24 h after injection of 308 FLC. (c) To date only IFN-a/0 has been shown to induce the expression of Mx protein in Mx' cells (24) . Injection of C57B1/6 mice with FLC resulted in the induced expression of the Mx protein in most cells of the liver, spleen (Fig . 10, B and E) , lung, and kidney, and this enhancement was blocked by treatment of the mice with anti-IFN-a/0 globulin (Fig. 10, C  and F) . The most likely explanation of our results appears to be that intravenous injection of 3C18 FLC results in the induction of IFN-a/0 that was neutralized by potent polyclonal antibody to IFN-a/0 .
We do not mean to imply, however, that IFN is the sole factor in determining the resistance of the liver to allogeneic tumor growth, but it does seem to be one of the important factors. IFN may also play a role in the resistance of the liver of syngeneic mice to FLC injected intravenously, but the effect is less obvious as the tumor cells multiply so rapidly. FLC injected intravenously into BALB/c mice (H-2d) congenic with A2G mice at the Mx locus also induced an increase in the expression of the Mx protein in the liver, spleen, lung, and kidney, therefore indicating the production of IFN-a/R (data not shown) . Injection of syngeneic DBA/2 mice (H-2d) with antibody to IFN-a/0 decreased the mean day of death from 9 .0 ± 0.6 d for control FLC-injected mice to 7 .0 ± 0 days for antibody-treated mice (p < 0.01) (data not shown) . Lastly, FLC do multiply in the livers of allogeneic nu/nu mice (data not shown) .
Landolfo and colleagues (37) showed that monoclonal antibodies to mouse IFN-y abrogated alloantigen recognition and induction of CTL in mixed leukocyte reactions. When allogeneic mice were injected with a fibrosarcoma, and treated repeatedly with an mAb to mouse IFN -y, tumor rejection did not occur. In our experiments, intravenous inoculation of FLC did not result in the appearance in any of the tissues tested of a poly(A)+ RNA hybridizable with a mouse IFN-y cDNA probe. Likewise, treatment of allogeneic C57B1/6 or C3H mice with a potent mAb to mouse IFN-y did not abrogate the resistance to multiplication of FLC in the liver (Fig . 8) . Thus, in our experiments we found no evidence that IFN-y played an important role, emphasizing once more the possibility that the site of tumor growth may elicit different host mechanisms and different inhibitory factors.
In our previous work (1) on the antitumor effects of IFN we have shown that administration of IFN markedly inhibits the multiplication of IFN-resistant 3C18 FLC in the liver and spleen of syngeneic DBA/2 mice, even after these cells were present in large numbers in these target organs . As we could show that these 3C18 FLC were resistant to several activities of IFN in vivo (as well in vitro) (38, 39) , we postulated that the antitumor effect of IFN was not due to a direct effect of IFN on the tumor cells themselves, but was host mediated (1) . The nature of the host mechanisms remains obscure, but we have found no evidence that humoral or cellular immune mechanisms played an important role (40) . Likewise, in the experiments reported herein we have used the IFN-resistant 3C18 line of FLC. As we still have no clear idea how exogenous IFN acts in syngeneic tumor-injected mice, it is premature to speculate how endogenous IFN might act in restricting FLC muliplication in the liver of allogeneic mice . In allogeneic mice treated with antibody to IFN-a/a, FLC multiplied to a far greater extent in the liver than in the spleen (Fig. 7) , whereas in syngeneic mice these FLC multiplied equally well in the liver and spleen . These results suggest that multiple factors are operative in determining the organ resistance to tumor cell multiplication and that IFN may be more important in the liver than in the spleen .
To our knowledge it is not known whether autochtonous primary or metastatic tumors in man elicit an IFN response . As tumor metastases in the liver do not always grow rapidly and exponentially, it seems reasonable to suggest that the rate of tumor growth in certain tissues may be determined not only by the inherent growth pattern of the individual tumor but also by the presence of soluble growth inhibitors such as IFN.
Likewise, it is unknown whether transplantation of normal liver induces an IFN response in the immunodepressed host, although it has been shown that IFN-a/0 is induced in mice in the course of graft-vs.-host disease (41) . The finding that in experimental animals "foreign liver is often better tolerated than other organ grafts (skin, kidney, or heart) being rejected less aggressively or requiring less immunosuppression to prevent rejection" (42) may suggest that mechanisms responsible for liver rejection are qualitatively or quantitatively different from those observed in other grafts . In a recent review on the immunology of liver transplantation in the rat, Kamada summarized as follows: "It seems quite likely that rejection of liver grafts across a whole haplotype barrier is under multigenic control, with important roles both for classical MHC-linked Ir genes and for non-MHC-linked background genes" (42) . If IFN production is important in liver transplantation it would be of interest to determine whether administration of antibody to IFN would facilitate liver (or other organ) transplantation in experimental animals (and possibly in man) .
Summary
Friend erythroleukemia cells (FLC) (H-2 d) injected intravenously into adult syngeneic DBA/2 or allogeneic C57B1/6 (H-2 b) or C3H (H-2 k) mice lodge in the liver but only multiply in the liver of syngeneic mice . Our results indicated that endogenous IFN-a/(3 was a crucial factor in preventing the multiplication of FLC in the liver of adult allogeneic mice . (a) Treatment of allogeneic adult C57BI/6 or C3H mice with polyclonal antibody to mouse IFN-a/0 (but not antibody to IFN-y) completely abrogated the resistance to the multiplication of FLC in the liver and 87% of tumor-injected, antibody-treated C57B1/6 mice died with extensive tumor involvement of the liver. In contrast, after intravenous inoculation FLC do not multiply at all (or very rarely) in the liver of adult C57B1/6 mice left untreated or treated with a variety of control globulins, and no deaths occurred . (b) 8 h after intravenous inoculation of FLC, poly(A)+ RNA hybridizable with specific DNA probes for mouse IFN-a or -R (but not -y) was present in the liver of injected C57BI/6 mice . Using the expression of the Mx protein as an indicator of the presence of IFN-a/R, we showed that Mx' congenic C57B1/6 mice injected with FLC exhibited a marked increase in the expression of the Mx protein in the liver, spleen, kidney and lung, and this increase was blocked by treatment of mice with antibody to IFN-a/0 . The possibility that different host mechanisms are elicited depending on the site of tumor growth in allogeneic mice is discussed. IFN-a/R appears to be of particular importance in determining the resistance of the liver to FLC in allogeneic mice .
